FOR INVESTORS

Disease outmatched by the science of degradation

FOR INVESTORS

FOR INVESTORS

Nurix is a clinical-stage biopharmaceutical company advancing targeted protein degradation as the next frontier in drug development.

Minimum 15 minutes delayed. Source: LSEG

SEC Filings

November 04, 2026

Filed by "insiders" prior intended sale of restricted stock.

November 04, 2026

Statement of changes in beneficial ownership of securities

November 04, 2026

Statement of changes in beneficial ownership of securities